| |
 |
|
|
|
|
|
Poster: 259
Visits: 78
Title: No survival benefit associated with routine imaging for classical Hodgkin lymphoma in complete remission: A Danish-Swedish population-based study
Authors: Tarec Christoffer El-Galaly ,
Centre: Aalborg University Hospital
|
|
You must be registered to reply or comment.
|
|
NO SURVIVAL BENEFIT ASSOCIATED WITH ROUTINE IMAGING FOR CLASSICAL HODGKIN LYMPHOMA IN COMPLETE REMISSION: A DANISH-SWEDISH POPULATION-BASED STUDY
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 10
Visits: 365
Title: Efficacy and Safety of Lenalidomide and Rituximab vs Placebo and Rituximab in a Phase 3 Trial in Relapsed/Refractory Non-Hodgkin Lymphoma
Authors: John Leonard , Marek Trne&711;n, Phillip Scheinberg, Kensei Tobinai, Nathan H. Fowler, Nurgul Kilavuz, Pierre Fustier, Barbara Amoroso, and John G. Gribben
Centre: Weill Cornell Medical College,
|
|
|
|
